Lorenzati, B.; Zucco, C.; Miglietta, S.; Lamberti, F.; Bruno, G.
Oral Hypoglycemic Drugs: Pathophysiological Basis of Their Mechanism of ActionOral Hypoglycemic Drugs: Pathophysiological Basis of Their Mechanism of Action. Pharmaceuticals 2010, 3, 3005-3020.
https://doi.org/10.3390/ph3093005
AMA Style
Lorenzati B, Zucco C, Miglietta S, Lamberti F, Bruno G.
Oral Hypoglycemic Drugs: Pathophysiological Basis of Their Mechanism of ActionOral Hypoglycemic Drugs: Pathophysiological Basis of Their Mechanism of Action. Pharmaceuticals. 2010; 3(9):3005-3020.
https://doi.org/10.3390/ph3093005
Chicago/Turabian Style
Lorenzati, Bartolomeo, Chiara Zucco, Sara Miglietta, Federico Lamberti, and Graziella Bruno.
2010. "Oral Hypoglycemic Drugs: Pathophysiological Basis of Their Mechanism of ActionOral Hypoglycemic Drugs: Pathophysiological Basis of Their Mechanism of Action" Pharmaceuticals 3, no. 9: 3005-3020.
https://doi.org/10.3390/ph3093005
APA Style
Lorenzati, B., Zucco, C., Miglietta, S., Lamberti, F., & Bruno, G.
(2010). Oral Hypoglycemic Drugs: Pathophysiological Basis of Their Mechanism of ActionOral Hypoglycemic Drugs: Pathophysiological Basis of Their Mechanism of Action. Pharmaceuticals, 3(9), 3005-3020.
https://doi.org/10.3390/ph3093005